PP2.2

139 views
98 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
139
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

PP2.2

  1. 1. Local Commissioning Advocates Commissioning in context Care pathway Supported by UCB Pharma through an educational grant. UCB has no editorial control on the contents. © Copyright Epilepsy Action 2012
  2. 2. NICE Clinical Guideline 137 (CG 137)Update and review of CG 20 (2004)Key priorities for implementationThe following recommendations havebeen identified as key priorities forimplementation.
  3. 3. Diagnosis• All adults with a recent-onset suspected seizure should be seen urgently* by a specialist**. This is to ensure precise and early diagnosis and initiation of therapy as appropriate to their needs.
  4. 4. Diagnosis• The seizure type(s) and epilepsy syndrome, aetiology and co-morbidity should be determined. Aetiology: cause or origin Co-morbidity: the presence of one or more other disorders
  5. 5. Management• Healthcare professionals should adopt a consulting style that enables the adult with epilepsy, and their family and/or carers as appropriate, to participate as partners in all decisions about their healthcare, and take fully into account their race, culture and any specific needs.
  6. 6. Management• All adults with epilepsy should have a comprehensive care plan that is agreed between the individuals, their family and/or carers as appropriate, and primary and secondary care providers.
  7. 7. Management• The AED (anti-epileptic drug) treatment strategy should be individualised according to the seizure type, epilepsy syndrome, co- medication and co-morbidity, the individual’s lifestyle, and the preferences of the individual, and their family and/or carers as appropriate.
  8. 8. Review and referral• All individuals with epilepsy should have a regular structured review. In adults, this review should be carried out at least yearly by either a generalist or specialist, depending on how well the epilepsy is controlled and/or the presence of specific lifestyle issues.
  9. 9. Review and referral• At the review, individuals should have access to: written and visual information; counselling services; information about voluntary organisations; epilepsy specialist nurses; timely and appropriate investigations; referral to tertiary services, including surgery as appropriate.
  10. 10. Review and referral• If seizures are not controlled and/or there is diagnostic uncertainty or treatment failure, individuals should be referred to tertiary services soon* for further assessment.
  11. 11. Special considerations for women of childbearing potential• Women with epilepsy and their partners, as appropriate, must be given accurate information and counselling about contraception, conception, pregnancy, caring for children, breastfeeding and menopause.
  12. 12. Care pathway• What should happen• When it should happen• How – best practice• By whom
  13. 13. Basic care pathway Pre-condition Recognition Diagnosis Treatment Continuing care
  14. 14. Pre-conditionNICE CG20 Recognition Diagnosis MANAGEMENT Treatment Continuing care
  15. 15. Local Commissioning Advocates Commissioning in context Care pathway Supported by UCB Pharma through an educational grant. UCB has no editorial control on the contents. © Copyright Epilepsy Action 2012

×